D-β-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board

Shigeru Nakamura, Michiko Shibuya, Hideo Nakashima, Tomohiro Imagawa, Masato Uehara, Kazuo Tsubota

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

PURPOSE. The purpose of this study was to establish a rat dry eye model of corneal epithelial disorders by inducing improper tear dynamics and change in blink frequency. The protective effect of D-β-hydroxybutyrate (HBA) on the corneal epithelia was also investigated. METHODS. A series of treatments were performed under continuous exposure to low-humidity airflow. Rats were placed on a jogging board (JB) made of a plastic pipe for 7.5 h/d, and, for 16.5 hours, they were placed in individual cages without JB treatment. The resultant changes in tear dynamics and corneal epithelial structure were then analyzed. Five days after the rats were exposed to the treatment, eyes that showed corneal fluorescein staining were examined, to investigate the effect of HBA, by administration of eye drops containing 80 mM HBA four times daily during JB treatment for 5 days. RESULTS. Significant reductions in blink frequency, Schirmer score, and tear clearance were recorded during JB treatment in eyes that showed persistent punctate staining of almost one half of the corneal surface. The application of HBA-containing eye drops significantly reduced the punctate staining compared with the initial or phosphate-buffered saline-treated eyes. CONCLUSIONS. This rat dry eye model, established by repeated JB treatment in desiccating conditions, induced abnormal tear dynamics and superficial punctate keratopathy similar to that in humans. These findings suggest the potential clinical application of HBA in corneal surface epithelial disorders in patients with moderate to mild dry eye.

Original languageEnglish
Pages (from-to)2379-2387
Number of pages9
JournalInvestigative Ophthalmology and Visual Science
Volume46
Issue number7
DOIs
Publication statusPublished - 2005

Fingerprint

Jogging
Hydroxybutyrates
Tears
Ophthalmic Solutions
Staining and Labeling
Therapeutics
Corneal Epithelium
Humidity
Fluorescein
Plastics
Phosphates

ASJC Scopus subject areas

  • Ophthalmology

Cite this

D-β-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board. / Nakamura, Shigeru; Shibuya, Michiko; Nakashima, Hideo; Imagawa, Tomohiro; Uehara, Masato; Tsubota, Kazuo.

In: Investigative Ophthalmology and Visual Science, Vol. 46, No. 7, 2005, p. 2379-2387.

Research output: Contribution to journalArticle

Nakamura, Shigeru ; Shibuya, Michiko ; Nakashima, Hideo ; Imagawa, Tomohiro ; Uehara, Masato ; Tsubota, Kazuo. / D-β-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board. In: Investigative Ophthalmology and Visual Science. 2005 ; Vol. 46, No. 7. pp. 2379-2387.
@article{49860a825535464085ca585e434067f9,
title = "D-β-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board",
abstract = "PURPOSE. The purpose of this study was to establish a rat dry eye model of corneal epithelial disorders by inducing improper tear dynamics and change in blink frequency. The protective effect of D-β-hydroxybutyrate (HBA) on the corneal epithelia was also investigated. METHODS. A series of treatments were performed under continuous exposure to low-humidity airflow. Rats were placed on a jogging board (JB) made of a plastic pipe for 7.5 h/d, and, for 16.5 hours, they were placed in individual cages without JB treatment. The resultant changes in tear dynamics and corneal epithelial structure were then analyzed. Five days after the rats were exposed to the treatment, eyes that showed corneal fluorescein staining were examined, to investigate the effect of HBA, by administration of eye drops containing 80 mM HBA four times daily during JB treatment for 5 days. RESULTS. Significant reductions in blink frequency, Schirmer score, and tear clearance were recorded during JB treatment in eyes that showed persistent punctate staining of almost one half of the corneal surface. The application of HBA-containing eye drops significantly reduced the punctate staining compared with the initial or phosphate-buffered saline-treated eyes. CONCLUSIONS. This rat dry eye model, established by repeated JB treatment in desiccating conditions, induced abnormal tear dynamics and superficial punctate keratopathy similar to that in humans. These findings suggest the potential clinical application of HBA in corneal surface epithelial disorders in patients with moderate to mild dry eye.",
author = "Shigeru Nakamura and Michiko Shibuya and Hideo Nakashima and Tomohiro Imagawa and Masato Uehara and Kazuo Tsubota",
year = "2005",
doi = "10.1167/iovs.04-1344",
language = "English",
volume = "46",
pages = "2379--2387",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "7",

}

TY - JOUR

T1 - D-β-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board

AU - Nakamura, Shigeru

AU - Shibuya, Michiko

AU - Nakashima, Hideo

AU - Imagawa, Tomohiro

AU - Uehara, Masato

AU - Tsubota, Kazuo

PY - 2005

Y1 - 2005

N2 - PURPOSE. The purpose of this study was to establish a rat dry eye model of corneal epithelial disorders by inducing improper tear dynamics and change in blink frequency. The protective effect of D-β-hydroxybutyrate (HBA) on the corneal epithelia was also investigated. METHODS. A series of treatments were performed under continuous exposure to low-humidity airflow. Rats were placed on a jogging board (JB) made of a plastic pipe for 7.5 h/d, and, for 16.5 hours, they were placed in individual cages without JB treatment. The resultant changes in tear dynamics and corneal epithelial structure were then analyzed. Five days after the rats were exposed to the treatment, eyes that showed corneal fluorescein staining were examined, to investigate the effect of HBA, by administration of eye drops containing 80 mM HBA four times daily during JB treatment for 5 days. RESULTS. Significant reductions in blink frequency, Schirmer score, and tear clearance were recorded during JB treatment in eyes that showed persistent punctate staining of almost one half of the corneal surface. The application of HBA-containing eye drops significantly reduced the punctate staining compared with the initial or phosphate-buffered saline-treated eyes. CONCLUSIONS. This rat dry eye model, established by repeated JB treatment in desiccating conditions, induced abnormal tear dynamics and superficial punctate keratopathy similar to that in humans. These findings suggest the potential clinical application of HBA in corneal surface epithelial disorders in patients with moderate to mild dry eye.

AB - PURPOSE. The purpose of this study was to establish a rat dry eye model of corneal epithelial disorders by inducing improper tear dynamics and change in blink frequency. The protective effect of D-β-hydroxybutyrate (HBA) on the corneal epithelia was also investigated. METHODS. A series of treatments were performed under continuous exposure to low-humidity airflow. Rats were placed on a jogging board (JB) made of a plastic pipe for 7.5 h/d, and, for 16.5 hours, they were placed in individual cages without JB treatment. The resultant changes in tear dynamics and corneal epithelial structure were then analyzed. Five days after the rats were exposed to the treatment, eyes that showed corneal fluorescein staining were examined, to investigate the effect of HBA, by administration of eye drops containing 80 mM HBA four times daily during JB treatment for 5 days. RESULTS. Significant reductions in blink frequency, Schirmer score, and tear clearance were recorded during JB treatment in eyes that showed persistent punctate staining of almost one half of the corneal surface. The application of HBA-containing eye drops significantly reduced the punctate staining compared with the initial or phosphate-buffered saline-treated eyes. CONCLUSIONS. This rat dry eye model, established by repeated JB treatment in desiccating conditions, induced abnormal tear dynamics and superficial punctate keratopathy similar to that in humans. These findings suggest the potential clinical application of HBA in corneal surface epithelial disorders in patients with moderate to mild dry eye.

UR - http://www.scopus.com/inward/record.url?scp=23244437842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244437842&partnerID=8YFLogxK

U2 - 10.1167/iovs.04-1344

DO - 10.1167/iovs.04-1344

M3 - Article

VL - 46

SP - 2379

EP - 2387

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 7

ER -